# Sylvamo Corp: financial statements, quarterly

SLVM · NYSE · CIK 1856485 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slvm.md) · [Financials](/companies/slvm/financials.md) · [Filings](/companies/slvm/filings.md) · [Insiders](/companies/slvm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slvm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [897](/filings/0001856485-24-000030.md) | [964 d](/filings/0001856485-26-000008.md) | [905](/filings/0001856485-25-000017.md) | [933](/filings/0001856485-25-000024.md) | [965](/filings/0001856485-25-000031.md) | [970 d](/filings/0001856485-26-000008.md) | [821](/filings/0001856485-26-000019.md) | [794](/filings/0001856485-26-000034.md) | [846](/filings/0001856485-25-000031.md) | [890 d](/filings/0001856485-26-000008.md) | [755](/filings/0001856485-26-000019.md) | [806](/filings/0001856485-26-000034.md) |
| Selling, general and administrative | $m | [89.0](/filings/0001856485-24-000030.md) | [95.0 d](/filings/0001856485-26-000008.md) | [74.0](/filings/0001856485-25-000017.md) | [82.0](/filings/0001856485-25-000024.md) | [74.0](/filings/0001856485-25-000031.md) | [81.0 d](/filings/0001856485-26-000008.md) | [73.0](/filings/0001856485-26-000019.md) | [72.0](/filings/0001856485-26-000034.md) | [68.0](/filings/0001856485-25-000031.md) | [68.0 d](/filings/0001856485-26-000008.md) | [73.0](/filings/0001856485-26-000019.md) | [69.0](/filings/0001856485-26-000034.md) |
| Operating income | $m | not reported | not reported | [72.0](/filings/0001856485-25-000017.md) | [122](/filings/0001856485-25-000024.md) | [150](/filings/0001856485-25-000031.md) | [109 d](/filings/0001856485-26-000008.md) | [44.0](/filings/0001856485-26-000019.md) | [30.0](/filings/0001856485-26-000034.md) | [98.0](/filings/0001856485-25-000031.md) | [79.0 d](/filings/0001856485-26-000008.md) | [(15.0)](/filings/0001856485-26-000019.md) | [14.0](/filings/0001856485-26-000034.md) |
| Interest expense | $m | [15.0](/filings/0001856485-24-000030.md) | [15.0 d](/filings/0001856485-26-000008.md) | [14.0](/filings/0001856485-25-000017.md) | [13.0](/filings/0001856485-25-000024.md) | [19.0](/filings/0001856485-25-000031.md) | [11.0 d](/filings/0001856485-26-000008.md) | [12.0](/filings/0001856485-26-000019.md) | [12.0](/filings/0001856485-26-000034.md) | [12.0](/filings/0001856485-25-000031.md) | [13.0 d](/filings/0001856485-26-000008.md) | [12.0](/filings/0001856485-26-000019.md) | [15.0](/filings/0001856485-26-000034.md) |
| Income tax | $m | [33.0](/filings/0001856485-24-000030.md) | [18.0 d](/filings/0001856485-26-000008.md) | [17.0](/filings/0001856485-25-000017.md) | [30.0](/filings/0001856485-25-000024.md) | [37.0](/filings/0001856485-25-000031.md) | [19.0 d](/filings/0001856485-26-000008.md) | [6.0](/filings/0001856485-26-000019.md) | [5.0](/filings/0001856485-26-000034.md) | [31.0](/filings/0001856485-25-000031.md) | [25.0 d](/filings/0001856485-26-000008.md) | [(3.0)](/filings/0001856485-26-000019.md) | [12.0](/filings/0001856485-26-000034.md) |
| Net income | $m | [58.0](/filings/0001856485-24-000030.md) | [49.0 d](/filings/0001856485-26-000008.md) | [43.0](/filings/0001856485-25-000017.md) | [83.0](/filings/0001856485-25-000024.md) | [95.0](/filings/0001856485-25-000031.md) | [81.0 d](/filings/0001856485-26-000008.md) | [27.0](/filings/0001856485-26-000019.md) | [15.0](/filings/0001856485-26-000034.md) | [57.0](/filings/0001856485-25-000031.md) | [33.0 d](/filings/0001856485-26-000008.md) | [(3.0)](/filings/0001856485-26-000019.md) | [(11.0)](/filings/0001856485-26-000034.md) |
| Diluted EPS | $ per share | [1.37](/filings/0001856485-24-000030.md) | not reported | [1.02](/filings/0001856485-25-000017.md) | [1.98](/filings/0001856485-25-000024.md) | [2.27](/filings/0001856485-25-000031.md) | not reported | [0.65](/filings/0001856485-26-000019.md) | [0.37](/filings/0001856485-26-000034.md) | [1.41](/filings/0001856485-25-000031.md) | not reported | [(0.08)](/filings/0001856485-26-000019.md) | [(0.28)](/filings/0001856485-26-000034.md) |
| Basic EPS | $ per share | [1.39](/filings/0001856485-24-000030.md) | not reported | [1.04](/filings/0001856485-25-000017.md) | [2.02](/filings/0001856485-25-000024.md) | [2.32](/filings/0001856485-25-000031.md) | not reported | [0.66](/filings/0001856485-26-000019.md) | [0.37](/filings/0001856485-26-000034.md) | [1.43](/filings/0001856485-25-000031.md) | not reported | [(0.08)](/filings/0001856485-26-000019.md) | [(0.28)](/filings/0001856485-26-000034.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Current assets | $m | [1,186](/filings/0001856485-23-000027.md) | [1,193](/filings/0001856485-25-000008.md) | [1,115](/filings/0001856485-24-000015.md) | [1,100](/filings/0001856485-24-000024.md) | [1,229](/filings/0001856485-24-000030.md) | [1,063](/filings/0001856485-26-000008.md) | [1,011](/filings/0001856485-25-000017.md) | [977](/filings/0001856485-25-000024.md) | [990](/filings/0001856485-25-000031.md) | [1,076](/filings/0001856485-26-000034.md) | [1,097](/filings/0001856485-26-000019.md) | [1,107](/filings/0001856485-26-000034.md) |
| Total assets | $m | [2,785](/filings/0001856485-23-000027.md) | [2,872](/filings/0001856485-25-000008.md) | [2,604](/filings/0001856485-25-000017.md) | [2,691](/filings/0001856485-24-000024.md) | [2,861](/filings/0001856485-24-000030.md) | [2,604](/filings/0001856485-26-000008.md) | [2,763](/filings/0001856485-26-000019.md) | [2,763](/filings/0001856485-26-000034.md) | [2,703](/filings/0001856485-25-000031.md) | [2,763](/filings/0001856485-26-000034.md) | [2,834](/filings/0001856485-26-000019.md) | [2,875](/filings/0001856485-26-000034.md) |
| Current liabilities | $m | [674](/filings/0001856485-23-000027.md) | [695](/filings/0001856485-25-000008.md) | [649](/filings/0001856485-24-000015.md) | [654](/filings/0001856485-24-000024.md) | [714](/filings/0001856485-24-000030.md) | [682](/filings/0001856485-26-000008.md) | [616](/filings/0001856485-25-000017.md) | [635](/filings/0001856485-25-000024.md) | [653](/filings/0001856485-25-000031.md) | [716](/filings/0001856485-26-000034.md) | [758](/filings/0001856485-26-000019.md) | [752](/filings/0001856485-26-000034.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [43.0](/filings/0001856485-23-000027.md) | [28.0](/filings/0001856485-25-000008.md) | [28.0](/filings/0001856485-24-000015.md) | [28.0](/filings/0001856485-24-000024.md) | [43.0](/filings/0001856485-24-000030.md) | [22.0](/filings/0001856485-26-000008.md) | [23.0](/filings/0001856485-25-000017.md) | [23.0](/filings/0001856485-25-000024.md) | [23.0](/filings/0001856485-25-000031.md) | [23.0](/filings/0001856485-26-000034.md) | [23.0](/filings/0001856485-26-000019.md) | [41.0](/filings/0001856485-26-000034.md) |
| Shareholders' equity | $m | [836](/filings/0001856485-24-000030.md) | [901](/filings/0001856485-26-000008.md) | [889](/filings/0001856485-25-000024.md) | [830](/filings/0001856485-25-000031.md) | [937](/filings/0001856485-25-000031.md) | [847](/filings/0001856485-26-000034.md) | [908](/filings/0001856485-26-000034.md) | [959](/filings/0001856485-26-000034.md) | [977](/filings/0001856485-25-000031.md) | [966](/filings/0001856485-26-000034.md) | [979](/filings/0001856485-26-000034.md) | [955](/filings/0001856485-26-000034.md) |

- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [197 d](/filings/0001856485-24-000030.md) | [167 d](/filings/0001856485-26-000008.md) | [27.0](/filings/0001856485-25-000017.md) | [115 d](/filings/0001856485-25-000024.md) | [163 d](/filings/0001856485-25-000031.md) | [164 d](/filings/0001856485-26-000008.md) | [23.0](/filings/0001856485-26-000019.md) | [64.0 d](/filings/0001856485-26-000034.md) | [87.0 d](/filings/0001856485-25-000031.md) | [94.0 d](/filings/0001856485-26-000008.md) | [(10.0)](/filings/0001856485-26-000019.md) | [38.0 d](/filings/0001856485-26-000034.md) |
| Capital expenditure | $m | not reported | not reported | [60.0](/filings/0001856485-25-000017.md) | [53.0 d](/filings/0001856485-25-000024.md) | [44.0 d](/filings/0001856485-25-000031.md) | [64.0 d](/filings/0001856485-26-000008.md) | [48.0](/filings/0001856485-26-000019.md) | [66.0 d](/filings/0001856485-26-000034.md) | [54.0 d](/filings/0001856485-25-000031.md) | [56.0 d](/filings/0001856485-26-000008.md) | [49.0](/filings/0001856485-26-000019.md) | [61.0 d](/filings/0001856485-26-000034.md) |
| Dividends paid | $m | [11.0 d](/filings/0001856485-24-000030.md) | [25.0 d](/filings/0001856485-26-000008.md) | [12.0](/filings/0001856485-25-000017.md) | [13.0 d](/filings/0001856485-25-000024.md) | [18.0 d](/filings/0001856485-25-000031.md) | [19.0 d](/filings/0001856485-26-000008.md) | [18.0](/filings/0001856485-26-000019.md) | [18.0 d](/filings/0001856485-26-000034.md) | [19.0 d](/filings/0001856485-25-000031.md) | [18.0 d](/filings/0001856485-26-000008.md) | [18.0](/filings/0001856485-26-000019.md) | [18.0 d](/filings/0001856485-26-000034.md) |
| Share repurchases | $m | [13.0 d](/filings/0001856485-24-000030.md) | [17.0 d](/filings/0001856485-26-000008.md) | [5.0](/filings/0001856485-25-000017.md) | [25.0 d](/filings/0001856485-25-000024.md) | [0.0 d](/filings/0001856485-25-000031.md) | [39.0 d](/filings/0001856485-26-000008.md) | [20.0](/filings/0001856485-26-000019.md) | [20.0 d](/filings/0001856485-26-000034.md) | [42.0 d](/filings/0001856485-25-000031.md) | [0.0 d](/filings/0001856485-26-000008.md) | [0.0](/filings/0001856485-26-000019.md) | [0.0 d](/filings/0001856485-26-000034.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [44.6](/filings/0001856485-23-000027.md) | [43.1](/filings/0001856485-24-000015.md) | [42.8](/filings/0001856485-24-000024.md) | [42.4](/filings/0001856485-24-000030.md) | [42.1](/filings/0001856485-25-000017.md) | [41.9](/filings/0001856485-25-000024.md) | [41.9](/filings/0001856485-25-000031.md) | [41.5](/filings/0001856485-26-000019.md) | [41.1](/filings/0001856485-26-000034.md) | [40.3](/filings/0001856485-25-000031.md) | [39.6](/filings/0001856485-26-000019.md) | [39.8](/filings/0001856485-26-000034.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 39,760,243 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001856485-26-000034.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.